Skip to main content
Article
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.
Nuclear Medicine Communications (2014)
  • Manuela Matesan, University of Washington
  • Joseph Rajendran, University of Washington
  • Oliver W. Press, University of Washington
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Rainer F. Storb, Fred Hutchinson Cancer Research Center
  • Ryan D. Cassaday, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • George Oliveira, Harvard University
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Publication Date
January 11, 2014
DOI
10.1097/MNM.0000000000000172
Citation Information
Manuela Matesan, Joseph Rajendran, Oliver W. Press, David G. Maloney, et al.. "90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution." Nuclear Medicine Communications Vol. 35 Iss. 11 (2014) p. 1132 - 1142
Available at: http://works.bepress.com/john-pagel/103/